MoneyWorks4Me

Lincoln Pharmaceuticals informs about disclosure of related party transactions

24 Nov 2022 Evaluate

In compliance with Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Lincoln Pharmaceuticals has informed that it enclosed disclosure of related party transactions in the specified format for the half year ended September 30, 2022. The same available on the website of the Company at www.lincolnpharma.com.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..